Evolus, Inc. Common Stock (EOLS) is a publicly traded Healthcare sector company. As of May 21, 2026, EOLS trades at $6.46 with a market cap of $432.67M and a P/E ratio of -9.80. EOLS moved +2.26% today. Year to date, EOLS is +8.93%; over the trailing twelve months it is -33.84%. Its 52-week range spans $3.86 to $17.82. Analyst consensus is strong buy with an average price target of $14.50. Rallies surfaces EOLS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
EOLS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. EOLS recently traded at $6.46. Market cap is $432.67M. P/E ratio is -9.80. Revenue is $301.79M.
| Metric | Value |
|---|---|
| Price | $6.46 |
| Market Cap | $432.67M |
| P/E Ratio | -9.80 |
| EPS | $-0.67 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.82 |
| 52-Week Low | $3.86 |
| Volume | 119 |
| Avg Volume | 0 |
| Revenue (TTM) | $301.79M |
| Net Income | $-43.42M |
| Gross Margin | 66.06% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $297.18M | $-51.64M | $-0.80 |
| 2024 | $266.27M | $-50.42M | $-0.81 |
| 2023 | $202.09M | $-61.69M | $-1.08 |
| 2022 | $148.62M | $-74.41M | $-1.33 |
5 analysts cover EOLS: 0 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $14.50.